Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2003 1
2005 1
2006 1
2010 1
2018 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.
García-Alfonso P, Díaz-Rubio E, Abad A, Carrato A, Massutí B, Ortiz-Morales MJ, Manzano Mozo JL, Muñoz A, Durán G, Sastre J, Safont MJ, Ferreiro R, Rivera F, González E, Valladares-Ayerbes M, Grávalos C, Alonso-Orduña V, Viéitez JM, Yubero A, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). García-Alfonso P, et al. Drugs Aging. 2021 Mar;38(3):219-231. doi: 10.1007/s40266-021-00834-w. Epub 2021 Feb 22. Drugs Aging. 2021. PMID: 33615402 Free PMC article.
Adjuvant docetaxel for high-risk, node-negative breast cancer.
Martín M, Seguí MA, Antón A, Ruiz A, Ramos M, Adrover E, Aranda I, Rodríguez-Lescure A, Grosse R, Calvo L, Barnadas A, Isla D, Martinez del Prado P, Ruiz Borrego M, Zaluski J, Arcusa A, Muñoz M, López Vega JM, Mel JR, Munarriz B, Llorca C, Jara C, Alba E, Florián J, Li J, López García-Asenjo JA, Sáez A, Rios MJ, Almenar S, Peiró G, Lluch A; GEICAM 9805 Investigators. Martín M, et al. N Engl J Med. 2010 Dec 2;363(23):2200-10. doi: 10.1056/NEJMoa0910320. N Engl J Med. 2010. PMID: 21121833 Free article. Clinical Trial.
[Ibero-Latinamerican Clinical Practical Guidelines on pediatric caustic esophagitis: Therapeutical aspects (Part 2)].
Pierre R, Neri S, Contreras M, Vázquez R, Ramírez LC, Riveros JP, Rondón L, Bautista Casasnovas A, Rodríguez-Herrera A, Navalón M, Soto P, Iglesias C, Fernández G, Dias JA, Ruiz CJ, Spolidoro J, Jorge J, Vila V. Pierre R, et al. Among authors: navalon m. Rev Chil Pediatr. 2020 Apr;91(2):289-299. doi: 10.32641/rchped.v91i2.1289. Rev Chil Pediatr. 2020. PMID: 32730551 Free article. Spanish.
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.
Aranda E, García-Alfonso P, Benavides M, Sánchez Ruiz A, Guillén-Ponce C, Safont MJ, Alcaide J, Gómez A, López R, Manzano JL, Méndez Ureña M, Sastre J, Rivera F, Grávalos C, García T, Martín-Valadés JI, Falcó E, Navalón M, González Flores E, Ma García Tapiador A, Ma López Muñoz A, Barrajón E, Reboredo M, García Teijido P, Viudez A, Cárdenas N, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD). Aranda E, et al. Among authors: navalon m. Eur J Cancer. 2018 Sep;101:263-272. doi: 10.1016/j.ejca.2018.06.024. Epub 2018 Jul 24. Eur J Cancer. 2018. PMID: 30054049 Clinical Trial.
A multicenter phase II study of irinotecan in patients with advanced colorectal cancer previously treated with 5-fluorouracil.
Méndez M, Salut A, García-Girón C, Navalon M, Diz P, García López MJ, España P, de la Torre A, Martínez del Prado P, Duarte I, Pujol E, Arizcun A, Cruz JJ. Méndez M, et al. Among authors: navalon m. Clin Colorectal Cancer. 2003 Nov;3(3):174-9. doi: 10.3816/ccc.2003.n.023. Clin Colorectal Cancer. 2003. PMID: 14706177 Clinical Trial.
[Ibero-latinamerican clinical practical guidelines on pediatric caustic esophagitis: Physiopathology and clinical-endoscopic diagnosis (1st Part)].
Pierre R, Neri S, Contreras M, Vázquez R, Ramírez LC, Riveros JP, Rondón L, Bautista Casasnovas A, Rodríguez-Herrera A, Navalón M, Soto P, Iglesias C, Fernández G, Dias JA, Ruiz CJ, Spolidoro J, Jorge J, Vila V. Pierre R, et al. Among authors: navalon m. Rev Chil Pediatr. 2020 Feb;91(1):149-157. doi: 10.32641/rchped.v91i1.1288. Epub 2020 Jan 28. Rev Chil Pediatr. 2020. PMID: 32730427 Free article. Spanish.
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.
Fonseca E, Grau JJ, Sastre J, García-Gómez JM, Rueda A, Pastor M, Lara MA, Navalón M, Berrocal A, Tisaire JL, Cruz JJ. Fonseca E, et al. Among authors: navalon m. Eur J Cancer. 2005 Jun;41(9):1254-60. doi: 10.1016/j.ejca.2005.02.019. Eur J Cancer. 2005. PMID: 15908196 Clinical Trial.
Irinotecan (CPT-11) combined with bolus 5-fluorouracil/leucovorin (Saltz regimen) as first-line chemotherapy of patients with advanced colorectal cancer.
Barceló R, López Vivanco G, Rivera F, GarcíaGirón C, Alonso M, Castañón C, Ramos M, Navalón M, Centelles M, Balcells M. Barceló R, et al. Among authors: navalon m. Anticancer Drugs. 2006 Jan;17(1):89-94. doi: 10.1097/01.cad.0000185181.80227.93. Anticancer Drugs. 2006. PMID: 16317295 Clinical Trial.